Jiang H - Search Results

1

Research on rat models of hypobaric hypoxia-induced pulmonary hypertension.

Ma TT, Wang Y, Zhou XL, Jiang H, Guo R, Jia LN, Chang H, Gao Y, Yao XY, Gao ZM, Pan L. Ma TT, et al. Among authors: jiang h. Eur Rev Med Pharmacol Sci. 2015 Oct;19(19):3723-30. Eur Rev Med Pharmacol Sci. 2015. PMID: 26502863 Free article.

2

[Cyclin-dependent kinase inhibitors in mammal cells].

Jiang H, Wang YC. Jiang H, et al. Sheng Li Ke Xue Jin Zhan. 1996 Apr;27(2):107-12. Sheng Li Ke Xue Jin Zhan. 1996. PMID: 9592231 Review. Chinese.

3

[Comparative pharmacokinetic study of two different ways of using L-asparaginase as the main drug in combination chemotherapy].

Wang Y, Jiang H, Xie X. Wang Y, et al. Among authors: jiang h. Zhonghua Xue Ye Xue Za Zhi. 1999 Nov;20(11):589-91. Zhonghua Xue Ye Xue Za Zhi. 1999. PMID: 11721378 Clinical Trial. Chinese.

4

[Progress in the research on CDK kinase inhibitor p21Cip1].

Jiang H, Wang YC. Jiang H, et al. Sheng Li Ke Xue Jin Zhan. 1998 Oct;29(4):339-41. Sheng Li Ke Xue Jin Zhan. 1998. PMID: 12501664 Review. Chinese. No abstract available.

5

Association of a hypoxia-inducible factor-3α gene polymorphism with superovulation traits in Changbaishan black cattle.

Deng Q, Gao Y, Jiang H, Chen CZ, Li CH, Yu WL, Chen X, Zhang JB. Deng Q, et al. Among authors: jiang h. Genet Mol Res. 2015 Nov 19;14(4):14539-47. doi: 10.4238/2015.November.18.17. Genet Mol Res. 2015. PMID: 26600513 Free article.

6

Ex vivo expansion of antigen-specific CD4+CD25+ regulatory T cells from autologous naïve CD4+ T cells of multiple sclerosis patients as a potential therapeutic approach.

Xiang YJ, Ren M, Jiang H, Yang TT, He Y, Ao DH, Wang YY, Zhang Q, He XJ, Gao XG, Liu GZ. Xiang YJ, et al. Among authors: jiang h. Eur Rev Med Pharmacol Sci. 2016 Dec;20(24):5261-5270. Eur Rev Med Pharmacol Sci. 2016. PMID: 28051239 Free article.

7

Effect of NF-κB inhibitor on Toll-like receptor 4 expression in left ventricular myocardium in two-kidney-one-clip hypertensive rats.

Jiang H, Qu P, Wang JW, Li GH, Wang HY. Jiang H, et al. Eur Rev Med Pharmacol Sci. 2018 May;22(10):3224-3233. doi: 10.26355/eurrev_201805_15084. Eur Rev Med Pharmacol Sci. 2018. PMID: 29863269 Free article.

8

Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway.

Zhang J, Jiang H, Liu DH, Wang GN. Zhang J, et al. Among authors: jiang h. Eur Rev Med Pharmacol Sci. 2019 Aug;23(15):6736-6743. doi: 10.26355/eurrev_201908_18565. Eur Rev Med Pharmacol Sci. 2019. PMID: 31378917 Free article.

9

Effect of atorvastatin on pulmonary arterial hypertension in rats through PI3K/AKT signaling pathway.

Wang YY, Cheng XD, Jiang H. Wang YY, et al. Among authors: jiang h. Eur Rev Med Pharmacol Sci. 2019 Dec;23(23):10549-10556. doi: 10.26355/eurrev_201912_19696. Eur Rev Med Pharmacol Sci. 2019. Retraction in: Eur Rev Med Pharmacol Sci. 2023 Sep;27(17):7881. doi: 10.26355/eurrev_202309_33543 PMID: 31841211 Free article. Retracted.

10

[Lifelong nutrition and the control of noninfectious chronic diseases].

Wang Y, Jiang H. Wang Y, et al. Among authors: jiang h. Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Feb 6;56(2):154-158. doi: 10.3760/cma.j.cn112150-20210731-00736. Zhonghua Yu Fang Yi Xue Za Zhi. 2022. PMID: 35184444 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,342 results

Search Page

Filters